PS92. Transradial Approach for the Treatment of Non-maturing Hemodialysis Fistulae May Have Better Patency Than Standard Direct Fistula Approach  by Smeraldi, Alessandro et al.
JOURNAL OF VASCULAR SURGERY
Volume 51, Number 11S Abstracts 43SMethods: A retrospective chart review showed 5 pa-
tients (1 in 1992, 4 since 2004) underwent vertebral to
common carotid transpositions. A systematic search for all
studies that evaluated VA interventions was done through
MEDLINE and bibliographic search. Various demo-
graphic and endpoint variables were extracted.
Results: Our case series comprises 5 patients (mean age:
75.4 years, M:F 4:1, symptomatic 100%). Shunts were used in
two cases. We had no wound complications or postoperative
morbidity. The mean follow was 23.8 months with no stroke/
TIAs and100%patencyonDoppler.Onepatientdied from lung
cancer 4 years after surgery and one 6 years after surgery from
unknown causes. 30 studies on VA stenting and/or angio-
plasty were identified (1981-2009). There were 8 studies
describing surgery (1984-2000). Following surgical treat-
ment, lower rates of restenosis (2.3%) were seen with longer
follow-up, but wound complications were relatively com-
mon. Restenosis was a problem after stent placement with
no difference between bare metal (27.7%) or drug eluting
stents (26.1%). The duration of follow-up and presence of
bilateral VA disease was significantly associated with reste-
nosis on regression analysis. Unexpectedly, degree of ste-
nosis was inversely related to degree of initial stenosis.
Conclusions: Surgery and endovascular interventions
have good initial technical success. Restenosis is problem-
atic with bare metal or drug-eluting stents. Surgery is
associated with a higher risk of wound complications but
provides superior longterm results.
Author Disclosures: S. Arya: Nothing to disclose; B. T.
Baxter: Nothing to disclose; I. Pipinos: Nothing to dis-
close; E. A. Waltke: Nothing to disclose; S. P. Watten-
hofer: Nothing to disclose.
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Carotid Artery Endarterectomy (CEA) for Stroke in
Evolution (SIE): Technical and Long-term Clinical
Outcome in a Tertiary Referral Vascular Centre. When
to Master Silence?
Sherif Sultan1, Niamh Hynes2. 1Vascular & Endovascular
Surgery, Western Vascular Institute, Galway, Ireland; 2Gal-
way Clinic, Galway, Ireland
Objectives: Scheduling of CEA in symptomatic carotid
artery stenosis (SCAS) remains controversial. No consensus
exists on management of crescendo TIAs (cTIA) or SIE.
We endeavour to evaluate 5-year survival rates and freedom
from stroke in patients with SCAS14days, cTIA and SIE.
Methods: Between 2002- 2008, 1847 patients were ap-
praisedwith carotid stenosis60%.ThePredicted Probability of
Receiving intervention was tabulated for all Patients by Using
Multiple Logistic Regressions to Control for Co-morbidity and
Anatomical High-risk Factors. Mean age was similar between
SCAS, 68.6 years and cTIA, 69.1 years (p0.05) but SIE pa-
tients were younger (67.2 years) than SCAS (p  0.01) or
CTIAS (p  0.05). SVS co-morbidity scores were similar
between groups (p  0.05). SCAS were less likely to haveecholucent plaque on duplex US (p  0.001). Fast Track
Clear Pathway Permitted rapid Triage and Management.
Results: Over all Death/stroke rate was 1.9% (Table
1). Compared to SCAS (87.9%) 5-year stoke-free survival
was not distinctive for cTIA (93.3%, p  0.818) or SIE
(92.9%, p  0.184). 5-year intervention free survival was
not diverse with SCAS (87%) compared to cTIA (91.1%,
p  0.889) or SIE (92.9%, p  0.231).
Conclusions: Indications for Emergency CEA are Li-
tigious. The menace of CEA is Drastically Higher in Neu-
rologically Unstable patients. Conversely Natural History
of Acute Carotid occlusion Without Surgery is Atrocious.
Emergency Surgery should be Indicated if it Propounds
Improved Outcomes Over Aggressive Medical Therapy.
Table 1
Symptomatic
14 days
Crescendo
TIAs
Stroke in
Evolution P Value
Number 359 300 (83.5%) 45 (12.5%) 14.4%
Stroke 2 (0.67%) 1 (2.2%) 1 (7.1%) 0.059
Death 2 (0.67%) 1 (2.2%) 0 (0%) 0.533
Author Disclosures: N. Hynes: Nothing to disclose; S.
Sultan: Nothing to disclose.
PS92.
Transradial Approach for the Treatment of Non-ma-
turing Hemodialysis Fistulae May Have Better Patency
Than Standard Direct Fistula Approach
Alessandro Smeraldi, Samir Pancholy, Jason Butchko.
Community Medical Center, Scranton, PA
Objectives: Percutaneous angioplasty of non-matured
proximal arm hemodialysis arteriovenous fistulae presents a
unique challenge given the frequently non-arterialized vein
and the awkward working angle. We describe our results
using a transradial artery approach.
Methods: All patients with proximal arm fistulae who
underwent percutaneous angioplasty between July 2007 and
July 2009 were included. The primary endpoints were tech-
nical success, successful cannulation and time required for
maturation. Data were retrospectively collected and analyzed.
Results: A total of 32 consecutive procedures were
performed in 25 patients with non-maturing brachioce-
phalic or brachiobasilic fistulae. Balloon angioplasty matu-
ration was accomplished either by a radial artery approach
(RABAM) or by a standard direct fistula approach (BAM).
The RABAM study group included 14 procedures in 11
patients and the control BAM group included 18 proce-
dures in 14 patients. Patients were followed for a mean of
9.2  8.4 months. Technical success was 100% in both
groups. Four patients, two in each group, died before they
could start dialysis. Successful cannulation was achieved
more frequently in the study group (RABAM, 77.8%;
BAM, 50%). The mean time to cannulation was shorter in
the study group (RABAM, 35.7  22.7 days; BAM,
87.5  68.7 days; p 0.05). Complications were few; one
asymptomatic radial artery thrombosis and one minor he-
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deaths as a result of any procedures.
Conclusions: A transradial artery approach for balloon
angioplasty maturation of proximal arm fistulae provides at
least equivalent success rates to a standard direct fistula
approach with minimal complications.
Author Disclosures: J. Butchko: Nothing to disclose; S.
Pancholy: Nothing to disclose; A. Smeraldi: Nothing to
disclose.
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The Use of Subclavian-Atrial Bypass for the Treatment of
Central Venous Hypertension Induced by Dialysis Access
Procedures
Diego A. Hernandez, Gonzalo P. Obnial, O William
Brown, Frank Baciewicz, Jeffrey J. Rubin. Wayne State
University School of Medicine, Detroit, MI
Objectives: Hemodialysis patients may encounter severe
complications as a result of central venous hypertension. The
increasing expertise with endovascular skills offers alternative
therapeutic options, but repeat procedures are common, and
when these fail, a more definitive intervention is necessary
Methods: We reviewed the records of 3 consecutive
patients presenting with massive upper extremity edema
and functioning but threatened dialysis grafts. All patients
had central venous hypertension due to subclavian or supe-
rior vena cava obstruction. These patients were evaluated
for either endovascular or open surgical treatment
Results: No patient was found to be suitable for an
endovascular approach. All 3 patients underwent subclavian-
atrial bypass with externally supported PTFE grafts via supra-
clavicular and mini-sternotomy incisions. All 3 patients were
discharged homewithin 5 days with no postoperative compli-
cations and with significant improvement in their edema. All
of the threatened grafts continue to function at 6 months, 1
year, and 3 years. One patient developed a late steal syndrome
successfully treated by a DRIL procedure
Conclusions: A Subclavian-atrial bypass appears to be a
viable treatment alternative in patients presenting with threat-
ened dialysis grafts and symptomatic upper extremity edema
secondary to central venous hypertension
Author Disclosures: F. Baciewicz: Nothing to disclose;
O. Brown: Nothing to disclose; D. A. Hernandez: Noth-
ing to disclose; G. P. Obnial: Nothing to disclose; J. J.
Rubin: Nothing to disclose.
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Screening for Carotid & Renal Stenosis in Patients
Undergoing Tesio Catheter Placement
Lin Roy, Anil Hingorani, Natalie Marks, Enrico Ascher,
Alexsander Shiferson, Kapil Gopal, Daniel Jung, Theresa
Jacob. Division of Vascular Services, Maimonides Medical
Center, Brooklyn, NYObjectives: An earlier report demonstrated that if the
prevalence of significant carotid disease to be greater than
4.5%, screeningmay be cost-effective.Many factors associated
with carotid artherosclerosis are shared with those of chronic
renal disease, and those patients who have severe renal artery
disease may eventually require Tesio catheter placement.
Therefore, we postulate performing carotid/renal duplex
scans in this high-risk population may be of benefit.
Methods: Between July 2005 and August 2009, 641
patients underwent tesio catheter placement. Of these, 136
patients underwent carotid duplexes perioperatively.
Results: 13 patients (9.6%) had60% stenosis, 8 patients
(5.9%) had 70-99% stenosis, and 5 patients (3.7%) had prior
CEA procedure, eachmutually exclusive. Sex was not a signif-
icant factor in the outcome of the carotid duplex scans. Of the
109 patients who underwent renal artery duplex, renal artery
stenosis was noted in 4.9% of the patients and 2 AAA’s were
noted.
Conclusions: Our results indicates a significant preva-
lence of carotid and renal artery stenosis for patients who will
also receive Tesio catheter placement, espescially for those
with history of coronary artery disease and60 years of age.
 60 % 50-70% 70-99% s/p CEA
no DM 10.9% 18.8% 6.3% 1.6%
DM 8.3% 22.2% 5.6% 5.6%
no CAD 3.4% 8.6% 3.4% 0
CAD 14.1% 29.5% 7.7% 6.4%
p value .042 .0028 .467 .071
no HTN 0 20% 0 10%
HTN 8.7% 30.2% 6.3% 3.2%
DM & CAD 12.5% 30% 7.5% 10%
60 y.o. 0 7.1% 0 0
61-80 y.o. 13.2% 27.9% 5.9% 2.9%
81 y.o. 10% 17.5% 10% 7.5%
Author Disclosures: E. Ascher: Nothing to disclose; K.
Gopal: Nothing to disclose; A. Hingorani: Nothing to
disclose; T. Jacob: Nothing to disclose; D. Jung: Nothing
to disclose; N. Marks: Nothing to disclose; L. Roy: Noth-
ing to disclose; A. Shiferson: Nothing to disclose.
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Technical Feasibility, Safety, and Efficacy of a Novel
Anastomotic Device (Optiflow™) for the Creation of
Arteriovenous Fistulae (AVF) for Hemodialysis
Roberto J. Manson1, Mark Mantell2, Adrian Ebner3,
Prabir Roy-Chaudhury4. 1Surgery, Duke University Med-
ical Center, Durham, NC; 2University of Pennsylvania,
Philadelphia, PA; 3Italian Hospital, Asuncion, Paraguay;
4University of Cincinnati, Cincinnati, OH
Objectives: Arteriovenous fistulae (AVFs) are the pre-
ferred dialysis vascular access. Over 50% of AVFs are unsuit-
able for dialysis (”maturation failure”) at 5 months, primar-
ily due to peri-anastomotic stenosis. The objective of the
study was to evaluate the technical feasibility, safety, and
efficacy of a novel anastomotic device for the creation of
arteriovenous fistula (AVF) for hemodialysis.
